/newsroom/ en /newsroom/news/list/2022/04/13/new-findings-show-effectiveness-of-meningococcal-b-vaccine-against-gonorrhoea Researchers at The ³ÉÈË´óƬ have found that the meningococcal B vaccine could improve protection against gonorrhoea in addition to protection against meningococcal B meningitis. April 13 2022 Lee Gaskin /newsroom/news/list/2022/04/13/new-findings-show-effectiveness-of-meningococcal-b-vaccine-against-gonorrhoea /newsroom/news/list/2022/03/08/professor-helen-marshall-a-leading-light The ³ÉÈË´óƬ’s Professor Helen Marshall, AM has been named South Australia’s 2022 Woman of the Year, in the Advertiser, Sunday Mail, SkyCity Inspirational Women of the Year Awards, acknowledging her dynamic contribution to medical research. March 08 2022 Michele Ann Nardelli /newsroom/news/list/2022/03/08/professor-helen-marshall-a-leading-light /newsroom/news/list/2021/07/22/life-saving-meningococcal-b-vaccination-program-continues-indefinitely South Australia's world-leading Meningococcal B Immunisation Program will continue indefinitely after proving it’s been incredibly effective at preventing the illness in high-risk age groups thanks to research at the ³ÉÈË´óƬ. July 22 2021 Elisa Black /newsroom/news/list/2021/07/22/life-saving-meningococcal-b-vaccination-program-continues-indefinitely /newsroom/news/list/2020/01/23/study-results-will-inform-immunisation-programs-globally The results of the B Part of It study – the largest meningococcal B herd immunity study ever conducted – are published today in the New England Journal of Medicine. January 23 2020 David Ellis /newsroom/news/list/2020/01/23/study-results-will-inform-immunisation-programs-globally